Published on 10 Apr 2022 on Simply Wall St. via Yahoo Finance
Here's What TCR2 Therapeutics Inc.'s (NASDAQ:TCRR) Shareholder Ownership Structure Looks Like
The big shareholder groups in TCR2 Therapeutics Inc. (NASDAQ:TCRR) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. We also tend to see lower insider ownership in companies that were previously publicly owned.
TCR2 Therapeutics is a smaller company with a market capitalization of US$104m, so it may still be flying under the radar of many institutional investors. Taking a look at our data on the ownership groups (below), it seems that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about TCR2 Therapeutics.
See our latest analysis for TCR2 Therapeutics